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Person-to-person transmission of a hantavirus was
first confirmed during a 1996 outbreak of hantavirus pul-
monary syndrome in southern Argentina, where Andes
virus is endemic. To identify other episodes of secondary
transmission, we reviewed reports of 51 cases of han-
tavirus infection from this region (November 1993–June
2005). Nine clusters involving 20 cases (39.2%) were
found. Two patients, who had symptoms 3 weeks after they
shared risks for rodent exposure, were considered a clus-
ter. The other 8 clusters each began with an index case,
which was almost always fatal, followed 19–40 days later
by the illness of at least 1 person who had close and pro-
longed contact with the index case-patient. Person-to-per-
son transmission was considered the probable source of
these 8 clusters. The probability of initiating secondary
cases was 41% for patients who died versus 4% for those
who survived (p = 0.005). Interpersonal transmission of
Andes virus infection should be considered even when
rodent exposure cannot be definitively excluded.
H
antaviruses (family Bunyaviridae, genus Hantavirus)
are rodentborne, zoonotic, lipid-enveloped RNA
viruses. Old World hantaviruses are associated with hem-
orrhagic fever with renal syndrome (HFRS), whereas New
World hantaviruses cause hantavirus pulmonary syndrome
(HPS) (1). Transmission to humans is thought to occur pre-
dominately by inhalation of infected rodent excreta (2).
Person-to-person transmission was first documented in
1996, when an HPS outbreak due to Andes virus in south-
ern Argentina provided reliable evidence for person-to-
person transmission of a hantavirus (3–5). In this region,
HPS was recognized in 1995 when an outbreak of respira-
tory illness in a family was investigated, and Andes virus
was identified from autopsy tissues of one of the case-
patients (6,7). Until now, Andes virus (reservoir
Oligoryzomys longicaudatus) was the only hantavirus
associated with human infections in this region and with
most HPS cases reported in Chile (8,9).
The 1996 HPS outbreak in southern Argentina showed
unique characteristics. The cases occurred in 3 cities over
an 11-week period, and each case-patient had proven con-
tact with another HPS case-patient. This unusual circum-
stance made it possible to identify the epidemiologic chain
(3,4). An identical viral nucleotide sequence in HPS case-
patients linked by interpersonal contact supported the
hypothesis of person-to-person transmission (5). Serious
outbreaks such as this are often fully investigated.
However, investigation resources are usually limited for
small outbreaks in HPS-endemic rural areas, so the epi-
demiologic diagnosis not easy to establish. To investigate
the possibility of other episodes of person-to-person trans-
mission, first proved in the 1996 outbreak, we reviewed
the epidemiology of HPS and cluster formation in our
region.
Materials and Methods
The HPS-endemic southern area in Argentina is locat-
ed in the western Patagonia region bordering Chile
(Figure 1). The area consists of the western strip of
Neuquen, Rio Negro, Chubut, and Santa Cruz provinces.
Since 1995, information about all cases of hantavirus
infection from Rio Negro and most of Neuquen has been
collected by M.E. Lázaro. Systematic registry used stan-
dardized forms, including surveillance case reports, results
of environmental and epidemiologic case investigations,
and clinical data. This registry was used to identify clusters
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June 2005. Case-patients who undoubtedly acquired the
infection in the region (resided in the area >45 days before
the onset of symptoms, had molecular evidence of Andes
virus infection, or both) were considered in this review.
A cluster was defined as the association of a patient
with confirmed HPS (index case-patient) with >1 contacts
who showed laboratory evidence of hantavirus infection
within 6 weeks of the onset of symptoms. Diagnostic con-
firmation was performed in referral centers (Instituto
Nacional de Enfermedades Virales Humanas “Dr. Julio
Maiztegui” and Instituto Nacional de Enfermedades
Infecciosas “Dr. Carlos Malbran”). Serologic specimens
were tested by ELISA for immunoglobulin M (IgM) and
IgG antibodies. RNA was extracted from tissue, blood
clots, or serum samples and amplified by reverse transcrip-
tion (RT)–PCR. Viral genotype was characterized by
sequencing the RT-PCR products.
When any HPS case was confirmed, an epidemiologic
investigation of the places where the patient had lived,
worked, or visited within the 6 weeks before the onset of
symptoms was immediately conducted. To determine the
most probable site of a patient’s exposure, we favored those
where rodents were trapped, handled, or seen, or where
rodent infestation was clearly evident (presence of excre-
ments, nests, or gnawed food). As soon as a case was con-
firmed, rodent traps were set in the potential exposure sites.
When a linked patient became ill, a new search that focused
on identifying common or persistent rodent sources and
possible interpersonal transmission was performed. A clus-
ter that occurred in 1994 was studied retrospectively.
HPS case-patients who needed mechanical ventilation
and hemodynamic support were considered to have a
severe clinical form, while those that did not require such
support were considered to have a moderate form.
Infections without pulmonary involvement were consid-
ered mild forms. 
Fisher exact test and Student t test were used to com-
pare independent variables; p <0.05 was considered signif-
icant. Epidemiologic records of 43 case-patients from Rio
Negro, 21 from Neuquen, and 3 from Chubut were
reviewed.
Of the 67 total cases, 16 belonged to the 1996 out-
break and were excluded from this study. Of the 51
patients whose cases were reviewed, hantavirus infection
was confirmed in 49. Acute infection was confirmed by
detection of specific IgM antibodies in 47 patients. In 15 of
them, the diagnosis was also confirmed by RT-PCR. Andes
genotype was characterized for all 15 cases. For the other
2 cases, specific IgG confirmed past infection. The remain-
ing 2 were potential HPS case-patients who died without
confirmed diagnosis because of lack of samples but who
were linked to close contacts with persons with confirmed
infection.
Among the 51 cases, 9 clusters involving 20 patients
(39.2%) were identified. Seven clusters met the strict clus-
ter definition of confirmed acute infection because specif-
ic IgM was detected for 16 case-patients in these clusters.
Each of the remaining 2 clusters was composed of a poten-
tial HPS case-patient (without confirmation due to lack of
samples) who died and a household contact of that patient
with confirmed infection.
Results
Two types of cluster were observed and depended on
the interval between cases (onset of symptoms). Type A
consisted of infections with <1 week between cases; type
B were those infections with >2 weeks between cases.
Type A Clusters 
Only 1 type A cluster was identified; it occurred in
August 2002. It involved a 10-year-old male student from
El Bolson and a 17-year-old male student from Bariloche.
They became ill 21 and 23 days, respectively, after return-
ing from a holiday week in El Manso, Rio Negro province,
a rural area bordering Chile, where they had both partici-
pated in high-risk activities: hunting excursions, games in
wilderness areas, and visits to stables. Both exhibited mod-
erate forms of HPS and survived. No risks were identified
in their respective houses in Bariloche and El Bolsón.
Type B Clusters
Eight type B clusters, comprising 18 patients, were
identified. Each was composed of an index case-patient,
followed 19–40 days later by the disease in ≥1 household
contact (Figure 2).
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Figure 1. Geographic origin of clusters (cl) of Andes virus cases,
southern Argentina. Cluster B1 took place in El Bolson, Rio Negro
province, in September 1994. A 21-year-old housewife,
who lived in a rural area and was breast-feeding her 7-
month-old daughter, died after she experienced a flulike
syndrome with acute respiratory distress. No samples were
available for etiologic diagnosis. Eight months later, dur-
ing a retrospective research study of contacts of persons
with suspected HPS, the baby was studied because her
mother fulfilled criteria for potential HPS. Antihantavirus
IgG without specific IgM was detected in the baby, so a
retrospective epidemiologic/ecologic study was per-
formed. A second sample obtained 2 years and 9 months
later confirmed past infection. Recollections by family
members supported asymptomatic infection.
Cluster B2 occurred in El Bolson, Rio Negro province,
in March and April 1995. A 38-year-old-man, who worked
as soft drink distributor, died of HPS. Three members of his
family showed laboratory evidence of acute infection with
different degrees of clinical severity: 1) his 25-year-old
pregnant girlfriend, a cashier in a supermarket, who did not
live with him (moderate form, survived); 2) his 9-year-old
son, a student, who lived with him (mild form, nonspecific
fever syndrome); and 3) his 15-year-old daughter, a student,
who lived with him (severe form, died). They became ill on
the 19th, 25th, and 27th day respectively, after the onset of
symptoms in the index case-patient. Some weeks before
becoming ill, the man had gone on a fishing excursion with
his girlfriend and son.
Cluster B3 took place in Loncopue, Neuquen
province, in November and December 1997. A41-year-old
man, a rural worker with suspected HPS, died while being
transferred to the hospital. Hantavirus infection was not
confirmed because of lack of samples. He had captured
and handled rodents and had observed rodent nests and
excrement at home and work. He had also cleaned several
unoccupied cabins. His wife, who was 31 years old, expe-
rienced symptoms 20 days later (severe form, survived).
Cluster B4 occurred in Bariloche, Rio Negro, in April
and May 2000. A26-year-old woman, who worked as gar-
dener, died of HPS. She lived and worked in a rural area
and had cleaned an uninhabited house 6 or 7 weeks before
becoming ill. Her husband, a 63-year-old gardener, had
onset of symptoms 20 days later (severe form, survived).
Cluster B5 happened in Lago Puelo, Chubut province,
in May 2000. A36-year-old woman was admitted to a hos-
pital in Bariloche with a moderate form of HPS (survived).
Her 3-year-old daughter, who was breast-feeding when her
mother became ill, showed symptoms 19 days later (fever,
vomiting, myalgia, and nasal congestion) but had no clini-
cal or radiologic signs of pulmonary involvement (mild
form). Seroconversion confirmed acute infection.
Cluster B6 occurred in Paraje El Morado, El Huecu,
Neuquen province, in May and June 2000. A 46-year-old
male farmer died of HPS. He was exposed to rodents at
work and home. His 10-year-old son became ill 19 days
later (severe form, died).
Cluster B7 occurred in Junin de los Andes, Neuquen
province, in April and May 2001. A 42-year-old male vet-
erinarian died of HPS. During the previous weeks he had
been conducting ecologic research in wilderness areas in
Neuquen and southern Chile. His wife, a 44-year-old
teacher, became ill 20 days later (moderate form, sur-
vived). They were separated and lived in neighboring
houses, but during the man’s illness he moved to his wife’s
home where she took care of him.
Cluster B8 took place in El Bolson, Rio Negro
province, in October and November 2003. A 31-year-old
male construction worker died of HPS. During the previ-
ous weeks he had cleared weeds from a wilderness area
and started building a cottage. His wife, a 28-year-old
housewife, became ill 40 days later (severe form, died).
She had not participated in the same potentially risky
activities as her husband.
Type B clusters involved family groups. Clusters B2,
B4, B5, B6, and B7 occurred during fall; clusters B1, B3,
and B8 occurred in spring. All patients lived in rural or
semirural areas. Each cluster was composed of 2 members,
except B2, which comprised 4 (Figure 2). Ten (55.5%)
patients were female. The average age was 28.3 ± 16.3
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Figure 2. Type B clusters of Andes virus infection, southern
Argentina. Mild forms of infection are indicated with an asterisk (*).
Horizontal lines join linked cases. Values above the lines indicate
the interval in days between the onset of symptoms of linked
cases. The relationship of secondary case-patients to index case-
patients is indicated at the far right.years (median 29.5 years; range 1–63 years); the baby of
B1 was 1 year old when specific IgG was detected, but she
had likely became infected at the age of 7 months, when
her mother was sick with the disease. Children <16 years
of age (28%) had secondary cases.
Andes genotype was identified in patients of cluster
B2 (1 case), B3 (1 case), and B4 (2 cases). Index case-
patients of clusters B3, B4, B6, B7, and B8 had occupa-
tional exposure. Exposure could have been either
occupational or recreational for the index case-patient of
B2. In B5, peridomestic and occupational exposure over-
lapped. In B1 (mother-baby), the study was retrospective
without any information about rodent exposure.
Secondary cases occurred in household or intimate
contacts of the respective index case-patients. Children
had daily direct contact (e.g., kissing, touching, hugging,
droplet spread) with their infected parents (B1, B2, B5,
B6). Sexual intercourse was another route to be consid-
ered for persons in clusters B2, B3, B4, and B8. In B1 and
B5, the mother was breast-feeding her child when she
became ill. Airborne transmission cannot be excluded for
any cluster.
When clusters B8 and B9 were studied, no evidence of
rodents was found in or around the patients’houses, and no
small mammals were captured. All trapped rodents related
to clusters B1 and B2 (49 rodents), B4 (9 rodents), and B5
(11 rodents) were seronegative for hantavirus. Information
about captured rodents associated with clusters B3 and B6
was not available. In 6 of the 8 clusters, no evidence for
rodent exposure by secondary case-patients was found. In
the other 2 clusters (B3 and B6), rodent exposure was
probable.
In 7 clusters, the average interval between symptom
onset in index case-patients and in secondary case-patients
was 23.4 ± 6.8 days (median 21 days; range 19–40 days)
(Figure 2). In B1, diagnosis was retrospective, and infec-
tion was subclinical in 1 of the 2 members, so determining
the interval was not possible.
Tested serum specimens from asymptomatic contacts
of HPS index case-patients showed no evidence of han-
tavirus infection. The baby from cluster B1, who exhibited
IgG antibodies, would be the exception. Contact surveil-
lance identified 2 acute infections (mild forms) in children,
by the presence of IgM antibodies (cluster B2) or by sero-
conversion (cluster B5).
All index case-patients had typical HPS symptoms.
Among patients with secondary cases, 7 of 10 fulfilled the
HPS definition. The remaining 3 were 2 children with mild
forms (clusters B2 and B4) and a baby with asymptomatic
infection (cluster B1). Index case-patients had a higher
death rate than patients with secondary cases (87.5% vs.
30%, p = 0.023). The death rate was also higher in index-
case-patients than in patients not included in type B clus-
ters (those with sporadic cases and cases in type Aclusters)
(87.5% vs. 30%, p = 0.005) (Table).
Among the 51 patients whose cases were initially
reviewed, 41 had undoubtedly acquired the infection from
rodents (secondary case–patients excluded). Seventeen of
these 41 died. Of the 17 patients who died, 7 (41%) had
become an index case-patient of a cluster. In contrast, only
1 (4%) of the 24 patients who survived became an index
case-patient (p = 0.005). These results indicate that the risk
of initiating secondary cases was associated with the most
severe manifestations.
Among the patients with sporadic cases and index
patients who died, no differences in clinical characteristics
were found. The mean number of days between onset of
symptoms and death (6.78 ± 2.23 vs. 6.86 ± 1.46, respec-
tively; p = 0.9) was similar for both groups.
Discussion
Both Old and New World hantavirus infections usual-
ly occur as sporadic cases (10). Although several persons
frequently are exposed to the same risks, they rarely
become infected. In a review of cases in the United States,
where most infections are caused by Sin Nombre virus, 12
(7.5%) of 160 patients were grouped in clusters. The pat-
tern of case manifestations and the fact that the members
of each cluster were exposed to sites with large infesta-
tions of rodents induced the authors to conclude that these
clusters originated from exposure to common rodent
sources (11).
In our study, 39.2% of the cases were grouped in clus-
ters; in addition, the 1996 outbreak was an extremely large
cluster (4,5). Patients in our cluster A lived in different
towns and became sick almost simultaneously, 3 weeks
after coming back from a wild area where they shared
high-risk activities. These characteristics suggest simulta-
neous exposure to a rodent source. Unlike the previous cat-
egory, type B clusters were characterized by an index
case-patient, who almost always died, followed 19–40
days later by the illness of >1 more close contacts of that
patient.
Although the incubation period for human hantavirus
illnesses is 8–45 days, it usually lasts 2–3 weeks (2). If the
members of each cluster type B were infected after a com-
mon exposure, the incubation period of the patients with
secondary cases would result from adding the estimated
incubation period for the index patient (2–3 weeks) to the
intervals between index and secondary cases. Under this
hypothesis, the incubation period for secondary cases to
develop would be abnormally long and rarely probable. On
the other hand, the average interval between index and sec-
ondary cases in type B clusters (23.4 days) was similar to
the average incubation period accepted for hantavirosis.
The former also matched the average interval among 1996
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the incubation period for person-to-person transmission.
Therefore, intervals between cases in type B clusters sug-
gest person-to-person transmission. In these clusters no
transmission from secondary case-patients was detected, in
contrast with the 1996 outbreak in which up to 4 link
chains were identified (4,5).
Another explanation for the long intervals could be
that infected peridomestic rodents contaminate the envi-
ronment, resulting in multiple transmissions over an
extended period. However, this possibility seems unlikely
for 4 reasons. First, for clusters B7 and B8, occupational
exposures, considered as the most likely risk for the index
case-patients, were excluded for the secondary case-
patients. In cluster B2, 3 of the patients shared a possible
common exposure (fishing excursion), but the fourth
(index case-patient’s daughter) did not. Second, immediate
actions to eliminate risk sources were taken when a patient
was detected, which lowered the risk for persisting domes-
tic or peridomestic rodent sources. Third, evidence of
domestic rodent infestation was absent for some clusters.
Fourth, no serologic reactivity was detected in rodents cap-
tured in peridomestic areas. Overall, although in any other
hantavirus outbreaks, multiple virus introductions to
humans from the environment are possible, clusters like
type B are the exception.
In any case, in the southern region of Argentina,
rodent exposure risks are difficult to exclude. Even in
urban zones, wild vegetation is intermingled with settle-
ments, and close contact with rural areas allows the circu-
lation of Oligoryzomys longicaudatus. This fact delayed
the suspicion for interpersonal transmission in the 1996
outbreak because the first case-patients lived in or visited
towns with these characteristics. Person-to-person trans-
mission was first strongly suspected when 1 patient was
transferred to a hospital outside of the Andes virus–endem-
ic area. The admitting physician, who had no other risk
factor for exposure, became ill with HPS 3 weeks later (3).
Recently, in a reported cluster caused by Andes virus
infection, the journey of the index case-patient out of the
Andes virus–endemic area was also the key to suspecting
person-to-person transmission (12,13). Therefore, person-
to-person transmission is evident only when special cir-
cumstances converge, as happens when an infected patient
spreads the virus out of the disease-endemic area. In this
situation, molecular studies are especially useful because
identical sequences in geographically separated but linked
cases support interpersonal transmission (5,12,13).
However, when all case-patients remain in the disease-
endemic area, infection may be attributed to other sources,
hiding the interpersonal transmission. In this situation,
molecular dissimilarities rule out person-to-person trans-
mission, but identical sequences do not support it. The
interval length may be helpful: a 2- to 4-week interval
among linked patients supports interpersonal transmission,
whereas a shorter interval suggests simultaneous exposure.
Reported clusters of Andes virus infection in southern
Chile showed the 2 patterns; some cases had intervals of
2–5 days, and others had intervals of >2 weeks between
cases (14,15).
An infection with high levels of virus replication
might correlate with the severity of the patient’s illness and
result in increased shedding of virus, which would initiate
secondary cases. Subsequent spread of the virus through
human hosts might induce a reduction of the initial viru-
lence, which would explain the lower death rate and mild
forms observed among patients with secondary cases. The
1996 outbreak may be explained by the circulation of a
uniquely virulent and transmissible virus strain or an
unusually high viral replication in a particular patient.
However, the human-to-human spread may show idiosyn-
cratic behavior of Andes virus as well as an extraordinary
situation. From this point of view, the 1996 outbreak can
be considered the maximum expression of person-to-per-
son spread. Human infections by Andes virus have also
shown distinctive clinical characteristics with more hem-
orrhagic, renal, hepatic, and muscular impairment than
those reported for Sin Nombre virus infection (16–20).
Although the mechanisms of person-to-person trans-
mission are still not clear, direct contact and aerosol trans-
mission must first be considered. Direct contact was
always taking place between family members (type B clus-
ters); because cough appears at the end of the febrile phase,
saliva may play an important role in transmission during
the early stages (as suggested by the detection of virus
antigen in rodents’ saliva glands) (21). For infected cou-
ples, sexual contact should also be considered, and breast-
feeding cannot be excluded in mother-baby clusters.
Aerosol infectivity can be suspected between persons
because the natural spread from rodents to persons is by
the aerosol route (22). Respiratory secretions may be
sources of infection because pulmonary involvement is
essential in HPS, viral antigen is present in pulmonary
endothelium (23,24), and Andes virus RNA has been
reported in tracheal secretions of infected persons (25).
Although in the 1996 outbreak, hospitals played a key
role in amplification, nosocomial transmission of Andes
virus seemed to be the exception (4,5). Under usual
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and limited to the early phase. Close and prolonged contact
may be necessary for interpersonal transmission.
Generally, the infection has already progressed to the car-
diopulmonary phase at the time of patient’s admission, so
healthcare workers are exposed during a late stage and do
not have close contact with the patient if they take ade-
quate biosafety measures. These facts may explain the
absence of HPS cases in healthcare workers during the
period reviewed and the low seroprevalence reported in
this group, which is similar to that of the general popula-
tion of the region (26,27). Seroprevalence in healthcare
workers may not be a sensible indicator of the need to
investigate person-to-person transmission of Andes virus
because such transmission mostly occurs in the patient’s
domestic circle during the early stages of the illness. In any
situation, universal precautions should be strictly fol-
lowed. Surgical masks with visor, gowns, and gloves
should be routinely worn and, whenever possible, addi-
tional measures such as using HEPA respirators and pro-
viding private rooms should be used to protect against
inspired particles.
Even though virus characterization was not performed
for all the cases reviewed, Andes virus is the unique geno-
type identified since 1995 in infected persons and rodents
in the southern region of Argentina. For this reason, Andes
virus is the most probable etiologic agent in those cases not
characterized.
The number of clusters identified during the period
reviewed is high compared with the low incidence of HPS
in the region. This finding suggests that person-to-person
transmission of Andes virus is not exceptional and must
always be suspected when the onset of symptoms of >2
case-patients linked by contact are separated by an interval
of ≈3 weeks. Case-patients with an ultimately fatal disease
have an increased risk of initiating secondary cases.
Surveillance of household contacts is useful for iden-
tifying mild symptoms. Contacts should be encouraged to
seeking immediate medical care if febrile symptoms
appear, and specific diagnostic tests must be performed.
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